Literature DB >> 10772678

Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort.

C J Newschaffer1, K Otani, M K McDonald, L T Penberthy.   

Abstract

BACKGROUND: Prostate cancer tends to affect older men and to progress relatively slowly. Since the prevalence of comorbidity increases with advancing age, competing causes of death are important contributors to death rates among prostate cancer patients. Accurate determination of the underlying causes of death in older men dying with prostate cancer may thus also be more difficult.
METHODS: We compared the distribution of underlying causes of death in decedents from a population-based cohort of elderly prostate cancer patients to that from a population-based comparison cohort of elderly men without prostate cancer. Among decedents from the prostate cancer patient cohort, we examined associations of patient demographics, disease stage, and initial treatment, with assignment of a prostate cancer underlying cause of death (versus any other cause) by use of multivariable logistic regression. In the subgroup of prostate cancer patient decedents having underlying causes of death other than prostate cancer, the underlying cause distribution was compared with that in nonprostate cancer cohort decedents.
RESULTS: Prostate cancer was the underlying cause for 39% (95% confidence interval [CI] = 36.3-41.9) of the decedents in the prostate cancer cohort. Causes of death among prostate cancer patients not dying of prostate cancer were similar to those among the nonprostate cancer cohort decedents. However, in those who were aggressively treated, the adjusted odds of other cancer causes of death were 51% higher (odds ratio [OR] = 1.51; 95% CI = 1.08-2.10) than that in nonprostate cancer patient decedents, while in those treated with watchful waiting the adjusted odds were 34% lower (OR = 0.66; 95% CI = 0.47-0.93).
CONCLUSIONS: Initial treatment may influence the underlying cause of death reported in vital statistics for prostate cancer patients.

Entities:  

Mesh:

Year:  2000        PMID: 10772678     DOI: 10.1093/jnci/92.8.613

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  46 in total

1.  Cause of death in older men after the diagnosis of prostate cancer.

Authors:  Melanie Ketchandji; Yong-Fang Kuo; Vahakn B Shahinian; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2008-11-18       Impact factor: 5.562

2.  Screening, treatment, and prostate cancer mortality in the Seattle area and Connecticut: fifteen-year follow-up.

Authors:  Grace Lu-Yao; Peter C Albertsen; Janet L Stanford; Therese A Stukel; Elizabeth Walker-Corkery; Michael J Barry
Journal:  J Gen Intern Med       Date:  2008-09-16       Impact factor: 5.128

3.  Radical prostatectomy versus observation for localized prostate cancer.

Authors:  Timothy J Wilt; Michael K Brawer; Karen M Jones; Michael J Barry; William J Aronson; Steven Fox; Jeffrey R Gingrich; John T Wei; Patricia Gilhooly; B Mayer Grob; Imad Nsouli; Padmini Iyer; Ruben Cartagena; Glenn Snider; Claus Roehrborn; Roohollah Sharifi; William Blank; Parikshit Pandya; Gerald L Andriole; Daniel Culkin; Thomas Wheeler
Journal:  N Engl J Med       Date:  2012-07-19       Impact factor: 91.245

Review 4.  Screening for prostate cancer: early detection or overdetection?

Authors:  Andrew J Vickers; Monique J Roobol; Hans Lilja
Journal:  Annu Rev Med       Date:  2011-11-03       Impact factor: 13.739

5.  Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group Practice.

Authors:  Michael J Barry
Journal:  J Gen Intern Med       Date:  2020-05       Impact factor: 5.128

Review 6.  Management of complications of androgen deprivation therapy in the older man.

Authors:  Supriya G Mohile; Karen Mustian; Kathryn Bylow; William Hall; William Dale
Journal:  Crit Rev Oncol Hematol       Date:  2008-10-25       Impact factor: 6.312

7.  Falls and physical performance deficits in older patients with prostate cancer undergoing androgen deprivation therapy.

Authors:  Kathryn Bylow; William Dale; Karen Mustian; Walter M Stadler; Miriam Rodin; William Hall; Mark Lachs; Supriya G Mohile
Journal:  Urology       Date:  2008-06-17       Impact factor: 2.649

Review 8.  [Statins and probiotics in the prevention of urologic diseases].

Authors:  C Fischer; J Altwein
Journal:  Urologe A       Date:  2007-06       Impact factor: 0.639

9.  [Survival of patients diagnosed with prostate cancer and monitored in primary care].

Authors:  Gabriel J Díaz Grávalos; Gerardo Palmeiro Fernández; Inmaculada Casado Górriz; Margarita Arandia García; Susana Alvarez Araújo; Mónica González Dacosta
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

10.  Prostate-cancer mortality in the USA and UK in 1975-2004: an ecological study.

Authors:  Simon M Collin; Richard M Martin; Chris Metcalfe; David Gunnell; Peter C Albertsen; David Neal; Freddie Hamdy; Peter Stephens; J Athene Lane; Rollo Moore; Jenny Donovan
Journal:  Lancet Oncol       Date:  2008-04-16       Impact factor: 41.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.